Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Gilbert

Showing results (11-20 of 173) with videos related to

Pageof 18
Sort By:
Kidney International|May 3, 2014
The Author's Reply:Richard E Gilbert
The Lancet. Diabetes & Endocrinology|September 22, 2015
Heart failure: fatal, forgotten, and frequent in type 1 diabetes tooRichard E Gilbert
Journal of Diabetes|April 17, 2013
Potential for cardiac protection with dipeptidyl peptidase-4 inhibitors: the stromal cell-derived factor-1α hypothesisRichard E Gilbert
Diabetes|March 23, 2017
Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney DiseaseRichard E Gilbert
Canadian Journal of Diabetes|February 7, 2014
Augmenting endothelial repair in diabetes: role of bone marrow-derived cellsRichard E Gilbert
Lancet (London, England)|July 18, 2003
Demographics and concomitant disorders in heart failureHenry Krum, Richard E Gilbert
Seminars in Nephrology|May 24, 2012
The endothelium in diabetic nephropathyAndrew Advani, Richard E Gilbert
Lancet (London, England)|May 27, 2015
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapyRichard E Gilbert, Henry Krum
European Journal of Heart Failure|February 11, 2016
Henry Krum, Pioneering Heart Failure ResearcherRichard E Gilbert, Frank Ruschitzka
Journal of Hypertension|December 5, 2006
Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disordersHenry Krum, Richard E Gilbert
Pageof 18

Showing results (11-20 of 173) with videos related to

Sort By:
Pageof 18
Kidney International|May 3, 2014
The Author's Reply:Richard E Gilbert
The Lancet. Diabetes & Endocrinology|September 22, 2015
Heart failure: fatal, forgotten, and frequent in type 1 diabetes tooRichard E Gilbert
Journal of Diabetes|April 17, 2013
Potential for cardiac protection with dipeptidyl peptidase-4 inhibitors: the stromal cell-derived factor-1α hypothesisRichard E Gilbert
Diabetes|March 23, 2017
Proximal Tubulopathy: Prime Mover and Key Therapeutic Target in Diabetic Kidney DiseaseRichard E Gilbert
Canadian Journal of Diabetes|February 7, 2014
Augmenting endothelial repair in diabetes: role of bone marrow-derived cellsRichard E Gilbert
Lancet (London, England)|July 18, 2003
Demographics and concomitant disorders in heart failureHenry Krum, Richard E Gilbert
Seminars in Nephrology|May 24, 2012
The endothelium in diabetic nephropathyAndrew Advani, Richard E Gilbert
Lancet (London, England)|May 27, 2015
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapyRichard E Gilbert, Henry Krum
European Journal of Heart Failure|February 11, 2016
Henry Krum, Pioneering Heart Failure ResearcherRichard E Gilbert, Frank Ruschitzka
Journal of Hypertension|December 5, 2006
Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disordersHenry Krum, Richard E Gilbert
Pageof 18